Recent advances and evolving concepts in Still's disease

P Ruscitti, L Cantarini, PA Nigrovic… - Nature Reviews …, 2024 - nature.com
Still's disease is a rare inflammatory syndrome that encompasses systemic juvenile
idiopathic arthritis and adult-onset Still's disease, both of which can exhibit life-threatening …

The latest advances in the use of biological DMARDs to treat Still's disease

I Di Cola, P Ruscitti - Expert Opinion on Biological Therapy, 2024 - Taylor & Francis
Introduction Currently, the therapeutic management of Still's disease, a multisystemic
inflammatory rare disorder, is directed to target the inflammatory symptoms and signs of …

Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

VE Saper, L Tian, RHJ Verstegen, CK Conrad… - The Journal of Allergy …, 2024 - Elsevier
Background After introducing IL-1/IL-6 inhibitors, some patients with Still and Still-like
disease developed unusual, often fatal, pulmonary disease. This complication was …

New Discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis

M Correia Marques, MJ Ombrello… - Expert Review of …, 2024 - Taylor & Francis
Introduction Systemic juvenile idiopathic arthritis (sJIA) is a severe inflammatory condition
with onset in childhood. It is sporadic, but elements of its stereotypical innate immune …

Innovations in the care of childhood interstitial lung disease associated with connective tissue disease and immune‐mediated disorders

A Samad, H Wobma, A Casey - Pediatric Pulmonology, 2024 - Wiley Online Library
Childhood interstitial lung disease (chILD) associated with connective tissue and immune
mediated disorders is the second most common chILD diagnostic category. As knowledge of …

Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an …

MG Matt, D Drozdov, E Bendstrup, M Glerup… - The Lancet …, 2024 - thelancet.com
Background Systemic juvenile idiopathic arthritis-related lung disease (sJIA-LD) is a severe
complication in patients with treatment-refractory systemic juvenile idiopathic arthritis (sJIA) …

Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study

W Zhan, J Yang, L Qiu, K Yang, X Ye… - Pediatric …, 2024 - Springer
Background Interstitial lung disease (ILD) is a serious complication in systemic juvenile
idiopathic arthritis (SJIA). This study aimed to identify the clinical characteristics and …

[HTML][HTML] Janus Kinase Inhibitors and Interstitial Lung Disease Associated With Pediatric Rheumatic Diseases: An Unexplored Field

E Sapountzi, L Fotis, E Kotanidou, L Fidani… - Cureus, 2023 - ncbi.nlm.nih.gov
Rheumatic diseases are often complicated by lung disease, commonly presenting as
interstitial lung disease (ILD), with potentially detrimental consequences for patient survival …

The place of JAK inhibitors in systemic juvenile idiopathic arthritis with lung disease: French experience

G Côte, P Quartier, A Belot, I Melki, V Hentgen… - …, 2024 - academic.oup.com
Objectives A new form of systemic juvenile idiopathic arthritis (SJIA) with associated lung
disease (SJIA-LD) has recently been described. Multiple lines of treatment have failed to …

Artropatías inflamatorias del niño

M Illiano, A Schvartz, I Koné-Paut - EMC-Tratado de Medicina, 2024 - Elsevier
La artritis juvenil idiopática es la primera causa de artropatías inflamatorias crónicas del
niño. Se trata de un grupo heterogéneo de patologías que engloban las artritis persistentes …